Literature DB >> 22553465

Biomarkers: Where to Go from Here.

Angelo Paradiso1.   

Abstract

Year:  2012        PMID： 22553465      PMCID： PMC3335353          DOI： 10.1159/000337179

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  8 in total

1.  Medical oncology: clinical value of circulating tumor cells in breast cancer.

Authors:  Stefan Sleijfer; John A Foekens
Journal:  Nat Rev Clin Oncol       Date:  2011-11-01       Impact factor: 66.675

2.  The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase.

Authors:  Emiel Rutgers; Martine J Piccart-Gebhart; Jan Bogaerts; Suzette Delaloge; Laura Van 't Veer; Isabel Teresa Rubio; Giuseppe Viale; Alastair M Thompson; Rodolfo Passalacqua; Ulrike Nitz; Anita Vindevoghel; Jean-Yves Pierga; Peter M Ravdin; Gustavo Werutsky; Fatima Cardoso
Journal:  Eur J Cancer       Date:  2011-11-01       Impact factor: 9.162

3.  Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine.

Authors:  Andreia de Albuquerque; Sepp Kaul; Georg Breier; Petra Krabisch; Nikos Fersis
Journal:  Breast Care (Basel)       Date:  2012-02-21       Impact factor: 2.860

4.  Analysis of Clinical Features and Outcome of 356 Triple-Negative Breast Cancer Patients in China.

Authors:  Li Zhang; Chunfang Hao; Guolei Dong; Zhongsheng Tong
Journal:  Breast Care (Basel)       Date:  2012-02-13       Impact factor: 2.860

5.  The Discriminatory Value of CYP2D6 Genotyping in Predicting the Dextromethorphan/Dextrorphan Phenotype in Women with Breast Cancer.

Authors:  Andreas Trojan; Athanasios Vergopoulos; Urs Breitenstein; Burkhardt Seifert; Christoph Rageth; Wolfgang Joechle
Journal:  Breast Care (Basel)       Date:  2012-02-20       Impact factor: 2.860

6.  The 70-Gene Signature as Prognostic Factor for Elderly Women with Hormone Receptor-Positive, HER2-Negative Breast Cancer.

Authors:  Steffi Hartmann; Bernd Gerber; Dirk Elling; Kristin Heintze; Toralf Reimer
Journal:  Breast Care (Basel)       Date:  2012-02-13       Impact factor: 2.860

Review 7.  The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review.

Authors:  N Fleeman; C Martin Saborido; K Payne; A Boland; R Dickson; Y Dundar; A Fernández Santander; S Howell; W Newman; J Oyee; T Walley
Journal:  Health Technol Assess       Date:  2011-09       Impact factor: 4.014

8.  Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study.

Authors:  Yinghao Su; Ying Zheng; Wei Zheng; Kai Gu; Zhi Chen; Guoliang Li; Qiuyin Cai; Wei Lu; Xiao Ou Shu
Journal:  BMC Cancer       Date:  2011-07-12       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.